Optipharm Co Ltd
153710
Company Profile
Business description
Optipharm Co Ltd is engaged in developing cell therapy products through animal stem cells, developing high value-added protein drugs using bio-reactors, selecting antibiotic/antiviral components and developing products. Its diagnosis division includes human diagnosis and animal diagnosis that focuses on the development of molecular diagnostics for a variety of diseases.
Contact
6, 63 Osong, Hwaseong-eup
Heungduk-gu
Chungcheongbuk-do
Cheongju
KORT: +82 432497500
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
77
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,969.90 | 10.20 | 0.13% |
| CAC 40 | 7,269.84 | 3.28 | -0.05% |
| DAX 40 | 21,118.96 | 164.13 | 0.78% |
| Dow JONES (US) | 40,524.79 | 312.08 | 0.78% |
| FTSE 100 | 8,180.84 | 46.50 | 0.57% |
| HKSE | 21,433.69 | 16.29 | 0.08% |
| NASDAQ | 16,831.48 | 107.03 | 0.64% |
| Nikkei 225 | 34,267.54 | 285.18 | 0.84% |
| NZX 50 Index | 12,011.34 | 96.20 | -0.79% |
| S&P 500 | 5,405.97 | 42.61 | 0.79% |
| S&P/ASX 200 | 7,761.70 | 13.10 | 0.17% |
| SSE Composite Index | 3,267.66 | 4.85 | 0.15% |